2-(N-Morpholino)ethanesulfonic acid monohydrate structure
|
Common Name | 2-(N-Morpholino)ethanesulfonic acid monohydrate | ||
|---|---|---|---|---|
| CAS Number | 145224-94-8 | Molecular Weight | 213.252 | |
| Density | 1.349 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C6H15NO5S | Melting Point | >300 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of 2-(N-Morpholino)ethanesulfonic acid monohydrateMES monohydrate (2-Morpholinoethanesulphonic acid monohydrate) is a buffer agent, which can be used for adjust the pH of growth medium to 5.5-7.0[1]. |
| Name | 2-morpholin-4-ylethanesulfonic acid,hydrate |
|---|---|
| Synonym | More Synonyms |
| Description | MES monohydrate (2-Morpholinoethanesulphonic acid monohydrate) is a buffer agent, which can be used for adjust the pH of growth medium to 5.5-7.0[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.349 g/cm3 |
|---|---|
| Melting Point | >300 °C(lit.) |
| Molecular Formula | C6H15NO5S |
| Molecular Weight | 213.252 |
| Exact Mass | 213.067093 |
| PSA | 84.45000 |
| LogP | 0.16080 |
| Water Solubility | H2O: 0.5 M at 20 °C, clear |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi:Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | QE3479500 |
| HS Code | 2934999090 |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo.
Oncotarget 6 , 39276-91, (2015) ATP-binding cassette subfamily G member 2 (ABCG2) is a member of the ABC transporter superfamily proteins, which has been implicated in the development of multidrug resistance (MDR) in cancer, apart f... |
|
|
Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1.
Biochem. Pharmacol. 90(4) , 367-78, (2014) Cancer cells often become resistant to chemotherapy through a phenomenon known as multidrug resistance (MDR). Several factors are responsible for the development of MDR, preeminent among them being th... |
|
|
Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin inhalation.
Mol. Pharm. 11(7) , 2334-45, (2014) Curcumin has potent antioxidant and anti-inflammatory properties but poor absorption following oral administration owing to its low aqueous solubility. Development of novel formulations to improve its... |
| 2-(4-Morpholinyl)ethanesulfonic acid hydrate (1:1) |
| 2-(N-Morpholino)ethanesulfonic acid,4-Morpholineethanesulfonic acid monohydrate |
| 4-Morpholineethanesulfonic acid, hydrate (1:1) |
| 2-Morpholinoethanesulfonic acid Monohydrate |
| 2-(4-morpholinyl)ethanesulfonic acid hydrate |
| 4-Morpholineethanesulfonic acid monohydrate |
| MFCD00149409 |
| 2-(Morpholin-4-yl)ethanesulfonic acid hydrate (1:1) |
| MES monohydrate |
| MES hydrate |
| EINECS 224-632-3 |
| 2-Morpholinoethanesulfonic acid hydrate |